Home Cart 0 Sign in  
X

[ CAS No. 98555-51-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 98555-51-2
Chemical Structure| 98555-51-2
Chemical Structure| 98555-51-2
Structure of 98555-51-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 98555-51-2 ]

Related Doc. of [ 98555-51-2 ]

Alternatived Products of [ 98555-51-2 ]

Product Details of [ 98555-51-2 ]

CAS No. :98555-51-2 MDL No. :MFCD07364745
Formula : C7H4BrNO4 Boiling Point : -
Linear Structure Formula :- InChI Key :WDDREAGLVSBXOG-UHFFFAOYSA-N
M.W : 246.02 Pubchem ID :15481066
Synonyms :

Calculated chemistry of [ 98555-51-2 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 5.0
Num. H-bond donors : 2.0
Molar Refractivity : 45.86
TPSA : 87.49 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.14 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.66
Log Po/w (XLOGP3) : 0.93
Log Po/w (WLOGP) : 1.24
Log Po/w (MLOGP) : -0.7
Log Po/w (SILICOS-IT) : 0.83
Consensus Log Po/w : 0.59

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.16
Solubility : 1.7 mg/ml ; 0.00691 mol/l
Class : Soluble
Log S (Ali) : -2.35
Solubility : 1.09 mg/ml ; 0.00443 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.63
Solubility : 5.75 mg/ml ; 0.0234 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.75

Safety of [ 98555-51-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 98555-51-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 98555-51-2 ]
  • Downstream synthetic route of [ 98555-51-2 ]

[ 98555-51-2 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 98555-51-2 ]
  • [ 113118-81-3 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1933, vol. <2> 138, p. 244,257
  • 2
  • [ 98555-51-2 ]
  • [ 20826-04-4 ]
Reference: [1] Yakugaku Zasshi, 1931, vol. 51, p. 542,571; dtsch. Ref. S. 73, 76[2] Chem.Abstr., 1931, p. 5427
[3] Journal fuer Praktische Chemie (Leipzig), 1933, vol. <2> 138, p. 244,257
[4] Chemische Berichte, 1886, vol. 19, p. 2766
[5] Monatshefte fuer Chemie, 1889, vol. 10, p. 705
  • 3
  • [ 98555-51-2 ]
  • [ 28733-43-9 ]
Reference: [1] Yakugaku Zasshi, 1931, vol. 51, p. 542,571; dtsch. Ref. S. 73, 76[2] Chem.Abstr., 1931, p. 5427
  • 4
  • [ 98555-51-2 ]
  • [ 29681-44-5 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1933, vol. <2> 138, p. 244,257
  • 5
  • [ 98555-51-2 ]
  • [ 20986-40-7 ]
Reference: [1] Yakugaku Zasshi, 1931, vol. 51, p. 542,571; dtsch. Ref. S. 73, 76[2] Chem.Abstr., 1931, p. 5427
  • 6
  • [ 5332-24-1 ]
  • [ 98555-51-2 ]
YieldReaction ConditionsOperation in experiment
48%
Stage #1: With ruthenium(IV) oxide; sodium hypochlorite In tetrachloromethane for 24 h;
Stage #2: With hydrogenchloride; water In tetrachloromethane
Example 12 2-Bromo-7-(4-fluoro-benzyl)-5,9-dihydroxy-pyrrolo[3,4-g]quinoline-6,8-dione 1008 Following the literature procedure of M.-D. Le Bas et al. (Synthesis 2001, 16, p. 2495), 100 ml CCl4 was mixed with 250 ml of an aqueous NaOCl solution. To this mixture was added 40 mg of RuO2, followed by 3 g 3-bromoquinoline dissolved in 50 ml CCl4. Additional 30 ml portions of bleach were added at 2, 4, and 6 h. After 24 h, the aqueous layer was collected and acidified to pH 1 with 3N HCl. The aqueous layer was then extracted with ethyl acetate, dried over Na2SO4 and volatiles removed by evaporation to give the 1.7 g product as a yellow resin, (48percent yield). 1H NMR and MS data matched that reported in the literature. The resulting anhydride, 1 g, was then carried through the previously reported multistep sequence to afford the corresponding cyano-ester. Dieckmann condensation between 80 mg (0.3 mmol) of the ester and 80 mg (3.6 mmol) of the imide utilizing 900 uL LiHMDS in 2 ml dry THF gave the crude product. After the typical work-up, approximately 60 mg (30percent) of unpurified product was obtained as a yellow solid which was further refined by trituration with diethyl ether to provide 2 mg highly pure product 1008. 1H NMR (300 MHz, d6-DMSO) δ 9.20 (d, 1H), 9.05 (d, 1H) and 4.85 (s, 2H) ppm, MS=416.1 (M+H).
25% With potassium permanganate In methanol; water at 20 - 80℃; for 1.5 h; To a mixture of 3-bromoquinoline (10 ml, 72.7 mmol) and water (20OmL) was added KMnO4 (69.0 g, 436 mmol) at 6 portion each 15 min at 80°C with stirring. After allowing the reaction to cool to rt, MeOH (20 mL) was added to the solution. The resulting mixture was washed with toluene (100 mL)5 and the aqueous layer was adjusted to pH 1 with cone. HCl. The mixture was extracted twice with EtOAc/THF (10OmL / 50 mL). The combined extracts were washed with brine, dried over Na2SO4, and the solvent was removed in vacuo. Water was added to the residue, the resulting insoluble materials were filtered off. Isobutyl acetate was added to the filtrate, and then water was removed in vacuo. The resulting precipitates were collected by filtration, and dried to give 4.45 g of compound B-2 (yield = 25 percent) as a colorless crystal. EPO <DP n="48"/>1H NMR (DMSO-(IO) δ 12.5O(1H, s), 8.9O(1H, d, J = 2.1 Hz), 8.43(1H, d, J = 2.1 Hz).
Reference: [1] Journal of Labelled Compounds and Radiopharmaceuticals, 2001, vol. 44, p. S283 - S285
[2] Synthesis, 2001, # 16, p. 2495 - 2499
[3] Patent: US2008/58315, 2008, A1, . Location in patent: Page/Page column 25-26
[4] Patent: WO2007/19098, 2007, A2, . Location in patent: Page/Page column 46-47
  • 7
  • [ 5332-24-1 ]
  • [ 110-19-0 ]
  • [ 98555-51-2 ]
YieldReaction ConditionsOperation in experiment
25% With potassium permanganate In water Compound B-2: 5-Bromo-pyridine-2,3-dicarboxylic acid
To a mixture of 3-bromoquinoline (10 ml, 72.7 mmol) and water (200 mL) was added KMnO4 (69.0 g, 436 mmol) at 6 portion each 15 min at 80° C. with stirring.
After allowing the reaction to cool to rt, MeOH (20 mL) was added to the solution.
The resulting mixture was washed with toluene (100 mL), and the aqueous layer was adjusted to pH 1 with conc. HCl.
The mixture was extracted twice with EtOAc/THF (100 mL/50 mL).
The combined extracts were washed with brine, dried over Na2SO4, and the solvent was removed in vacuo.
Water was added to the residue, the resulting insoluble materials were filtered off.
Isobutyl acetate was added to the filtrate, and then water was removed in vacuo.
The resulting precipitates were collected by filtration, and dried to give 4.45 g of compound B-2 (yield=25percent) as a colorless crystal.
1H NMR (DMSO-d6) δ 12.50 (1H, s), 8.90 (1H, d, J=2.1 Hz), 8.43 (1H, d, J=2.1 Hz).
Reference: [1] Patent: US2015/225399, 2015, A1,
  • 8
  • [ 69268-39-9 ]
  • [ 98555-51-2 ]
Reference: [1] Chemische Berichte, 1886, vol. 19, p. 2884
  • 9
  • [ 860758-00-5 ]
  • [ 98555-51-2 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1913, vol. 396, p. 27
  • 10
  • [ 5332-24-1 ]
  • [ 98555-51-2 ]
  • [ 5651-01-4 ]
Reference: [1] Chemische Berichte, 1886, vol. 19, p. 2766
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 98555-51-2 ]

Bromides

Chemical Structure| 351003-02-6

[ 351003-02-6 ]

5-Bromo-2-methylnicotinic acid

Similarity: 0.90

Chemical Structure| 886365-43-1

[ 886365-43-1 ]

5-Bromo-3-methylpicolinic acid

Similarity: 0.88

Chemical Structure| 213771-32-5

[ 213771-32-5 ]

Methyl 5-bromo-3-methylpicolinate

Similarity: 0.84

Chemical Structure| 794592-13-5

[ 794592-13-5 ]

Ethyl 5-bromo-3-methylpicolinate

Similarity: 0.82

Chemical Structure| 30766-11-1

[ 30766-11-1 ]

5-Bromopicolinic acid

Similarity: 0.80

Carboxylic Acids

Chemical Structure| 351003-02-6

[ 351003-02-6 ]

5-Bromo-2-methylnicotinic acid

Similarity: 0.90

Chemical Structure| 886365-43-1

[ 886365-43-1 ]

5-Bromo-3-methylpicolinic acid

Similarity: 0.88

Chemical Structure| 53636-65-0

[ 53636-65-0 ]

5-Methylpyridine-2,3-dicarboxylic acid

Similarity: 0.86

Chemical Structure| 30766-11-1

[ 30766-11-1 ]

5-Bromopicolinic acid

Similarity: 0.80

Chemical Structure| 192642-85-6

[ 192642-85-6 ]

2-(5-Bromopyridin-2-yl)acetic acid

Similarity: 0.77

Related Parent Nucleus of
[ 98555-51-2 ]

Pyridines

Chemical Structure| 351003-02-6

[ 351003-02-6 ]

5-Bromo-2-methylnicotinic acid

Similarity: 0.90

Chemical Structure| 886365-43-1

[ 886365-43-1 ]

5-Bromo-3-methylpicolinic acid

Similarity: 0.88

Chemical Structure| 53636-65-0

[ 53636-65-0 ]

5-Methylpyridine-2,3-dicarboxylic acid

Similarity: 0.86

Chemical Structure| 213771-32-5

[ 213771-32-5 ]

Methyl 5-bromo-3-methylpicolinate

Similarity: 0.84

Chemical Structure| 794592-13-5

[ 794592-13-5 ]

Ethyl 5-bromo-3-methylpicolinate

Similarity: 0.82